Celltrion Group provides biosimilar and innovative biopharmaceutical medications to increase patient access to therapies worldwide.
Base: 5 million yen to 6 million yen; Bonus/Equity: Not specified; Benefits: Includes sales allowance
Must-have
Nice-to-have
Not specified